跳至主要内容
临床试验/NCT01493206
NCT01493206已完成2 期

A Prospective Single Arm Study of Intraoperative Radiotherapy for Locally Advanced or Recurrent Rectal Cancer

Peter MacCallum Cancer Centre, Australia2 个研究点 分布在 1 个国家目标入组 32 人开始时间: 2004年7月1日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
32
试验地点
2
主要终点
clinical outcomes

研究概览

简要总结

The hypothesis is that intraoperative radiotherapy for locally advanced or recurrent rectal cancer improve outcomes without causing significant side effects.

详细描述

Primary Outcome measures are 3-year locoregional control, progression-free and overall survival rates.

Secondary outcome measures are toxicities scores up to 3 months after surgery (acute) and greater than 3 months after surgery (late). Data collected at 3-6 month intervals for 30 months

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • locally advanced or recurrent rectal cancer
  • suitable for radical surgery but at high risk of positive resection margins,
  • no evidence of metastasis,
  • age greater than 18 years,
  • histologically confirmed adenocarcinoma,
  • ECOG performance status <
  • Informed consent

排除标准

  • unresectable pelvic disease
  • distant metastasis
  • significant co-morbidities

结局指标

主要结局

clinical outcomes

时间窗: 3-year

locoregional control, progression-free and overall survival rates.

次要结局

  • toxicities(3-6 monthly up to 30 months)

研究者

发起方
Peter MacCallum Cancer Centre, Australia
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验